A widely used breast cancer drug could give IVF a boost, with new research showing that adding it to the standard hormone ...
In a new Dartmouth Cancer Center (DCC) study led by clinical researcher Tyler J. Curiel, MD, MPH, FACP, investigators found ...
Telmisartan, an FDA-approved blood pressure drug, could boost a certain cancer treatment's effectiveness against tumors, a ...
This might come as a surprise to many but an affordable blood pressure medication typically used to treat hypertension could ...
The combination of letrozole with a GnRH antagonist protocol in patients with expected POR (Patient-Oriented Strategies Encompassing Individualized Oocyte Number groups 3 and 4) reduced the mean total ...
Most of the oncology drugs that received the FDA’s accelerated approval from 2011 to 2020 had some kind of FDA postmarketing safety action, according to a research letter. Safety actions included ...
Please provide your email address to receive an email when new articles are posted on . Most oncology drugs that received FDA accelerated approval between 2011 and 2020 required postmarketing safety ...
Commonly prescribed heart medications, including statins and diuretics, do not negatively affect the survival of patients with multiple myeloma. SHARJAH, EMIRATE OF ...
Introduction Cancer is a leading cause of death globally. Breast cancer accounts for 30% of all cancer cases and 15% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results